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Proopiomelanocortin (POMC)-producing cells comprise nearly 100% of the adult rat intermediate lobe (IL) hormone-
producing cells. Secretion by these cells in the adult is primarily under negative regulation by dopamine. Although the
POMC-derived peptide a-MSH has been detected in plasma of fetal rats, the secretory capability of fetal melanotrophs has
not yet been examined directly. Here we have used the reverse hemolytic plaque assay to assess, at the single-cell level,
basal and regulated release by melanotrophs from fetal and early postnatal ages. Basal secretion was detected at the earliest
age examined [Embryonic Day 17.5 (e17.5)], but CRH (1008 M) stimulated secretion was not observed until e19.5. As
development proceded, CRH increased both individual plaque sizes and the percentage of melanotrophs stimulated to
secrete. An unexpected, transient inhibition of CRH stimulated release from melanotrophs by dexamethasone (DEX, 1006
M) was observed from e19.5±p2 (postnatal Day 2). By p3, however, DEX no longer inhibited melanotroph secretion while
inhibition of CRH-stimulated release from p3 corticotrophs was readily detected. The dopamine agonist ergocryptine (ERG,
1006 M) inhibited basal secretion from melanotrophs, but not corticotrophs, at all ages examined. Taken together, these
results indicate that melanotrophs undergo a maturation process in which they are initially nonresponsive to CRH, next
possess functional CRH and steroid receptors, and ®nally, undergo functional uncoupling of steroid receptors which charac-
terizes the adult IL. The loss of steroid-mediated inhibition of stimulated secretion parallels the arrival of catecholaminergic
input into the IL. In contrast, the early response of melanotrophs to dopaminergic agonists, which can be detected 1 week
prior to arrival of catecholaminergic ®bers into the neurointermediate lobe, appears to be an intrinsic feature of these cells
that is never present in corticotrophs. q 1996 Academic Press, Inc.
INTRODUCTION ventral neural ridge. Although the AL and IL share a com-
mon origin, the main products of POMC precursor pro-
cessing differ between adult IL and AL POMC cells (EipperIn the adult rat, the intermediate lobe (IL) of the pituitary
and Mains, 1980). In addition, there are several major differ-gland is a quite homogeneous tissue comprised principally
ences in the regulation of synthesis and secretion of POMC-of proopiomelanocortin (POMC)-derived peptide producing
derived peptides in each lobe. For example, although bothcells (Howe, 1973; Chronwall et al., 1987). Both the IL and
adult AL corticotrophs and IL melanotrophs have CRH re-anterior lobe (AL) develop from Rathke's pouch, which has
ceptors and respond to CRH incubation with increased se-been shown in the chick (Couly and LeDourain, 1985) and
cretion of POMC-derived peptides, CRH receptors are lessamphibian (Eagleson et al., 1986) to arise from the anterior
abundant in the IL (DeSouza et al., 1984) and a 10-fold
higher CRH concentration is needed to stimulate secretion
from melanotrophs compared to corticotrophs (Meunier et1 Present address: Department of Neuroscience and Cell Biology,
al., 1982; Vale et al., 1983). In addition, adult melanotrophs,UMDNJ-Robert Wood Johnson Medical School, 675 Hoes Lane,
but not corticotrophs, are under inhibitory regulation byPiscataway, New Jersey 08854.
hypothalamic dopamine (Munemura et al., 1980; Vermes2 To whom correspondence should be addressed. Fax: 908-235-
4990. et al., 1980). Finally, in contrast to the adult corticotrophs,
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the melanotrophs lack functional glucocorticoid receptors dopamine agonists in vitro (Antakly et al., 1987), a major
focus of this study was to determine whether the melano-(GR) (Schachter et al., 1982; Eberwine and Roberts, 1984;
Seger et al., 1988) and thus glucocorticoids do not inhibit troph response to glucocorticoids differed at ages prior to
and after arrival of dopaminergic input into the IL.CRH-stimulated POMC secretion from these cells. How-
ever, if the IL is subject to denervation (Seger et al., 1988) or
the IL cells are cultured (Eberwine et al., 1987), GR receptor
function can be detected. Incubation with dopamine or do- MATERIALS AND METHODS
pamine agonists inhibits the appearance of GR in cultured
IL cells, as detected by [3H]DEX (dexamethasone) binding In general, methods used for this study were identical to
those described in the accompanying paper (Lugo andand GR immunocytochemistry (Antakly et al., 1987),
which suggested to us that the status of GR presence/func- Pintar, 1996). For speci®c descriptions of methods used to
couple ovine red blood cells (oRBC) to staphylococcal pro-tion in the developing IL might vary as innervation pro-
cedes. tein A and to determine the ef®ciency of coupling, and for
general aspects of the reverse hemolytic plaque assay, theWhile immunocytochemical (Dupouy and Dubois, 1975;
Chatelain et al., 1979; Watanabe and Daikoku, 1979; basal secretion protocol, immunocytochemistry, and data
analysis, see appropriate sections in the accompanying pa-Schwartzberg and Nakane, 1982; Kachaturian et al., 1983;
Pintar and Lugo, 1987; Lugo et al., 1989) as well as in situ per (Lugo and Pintar, 1996). The sections below include
speci®c methods used to isolate or investigate NIL-derivedhybridization studies (Pintar and Lugo, 1987; Lugo et al.,
1989) have shown the presence of POMC cells in the fetal cells.
IL, studies on the secretory capabilities of these cells during
development is limited. Only a few studies have been car-
Neurointermediate Lobe Cell Dispersionried out in the human (Gibbs et al., 1982), sheep (Newman
et al., 1987), and rat fetus (Davis et al., 1984) as well as the Sources of NIL cells were embryos (e17.5, e19.5, and e21)
isolated from decapitated timed-pregnant mothers and neo-neonatal rat (Davis et al., 1984; Sato and Mains, 1986) and
mouse (Schmitt et al., 1981) and no study thus far has as- nates (p2, p3, and p5). Isolated fetuses and neonates were
decapitated, the pituitary glands removed, and AL and NILsessed directly, at the single-cell level, the secretory capabil-
ities of fetal melanotrophs and the development of respon- separated. Isolated NIL from 10 to 18 animals (one to two
litters) were pooled and dispersed as described in the accom-siveness to regulators of secretion. Furthermore, with the
exception of the studies in the human fetus (Gibbs et al., panying paper (Pituitary Cell Dispersion, under Materials
and Methods; Lugo and Pintar, 1996).1982), all other fetal studies have been carried out in vivo.
Since sites other than the pituitary gland synthesize POMC
mRNA and secrete POMC peptides, the origin of circulating
Studies on Stimulation of POMC-Derived Peptidepeptides cannot be accurately determined in these studies
Secretion from Melanotrophs(see Lugo and Pintar, 1996, for references). Moreover, the
effect of in vivo physiologic conditions in modulating re- Studies examining stimulated secretion were performed
identically to those on basal secretion but with the additionsponses of individual cells or groups of cells cannot be evalu-
ated. of the secretagogue CRH (1007 M) together with the antise-
rum (Smith et al., 1986). Initial experiments were conductedAs shown in the accompanying paper (Lugo and Pintar,
1996), the reverse hemolytic plaque assay, which was ini- utilizing different CRH concentrations in order to deter-
mine the CRH concentration that resulted in the largesttially developed to study individual antigen-secreting cells
(Molinaro et al., 1981), can be utilized informatively to increase in melanotroph plaque area as compared to basal
levels. The highest concentration used, CRH 1007 M, pro-study the ontogeny of the secretory response of cortico-
trophs. Here, we have utilized this assay to study the ontog- duced the largest plaques and was used in all subsequent
experiments.eny of basal and regulated secretion from individual mela-
notrophs from isolated neurointermediate lobes (NIL).
These studies were carried out beginning at Embryonic
Inhibition of POMC-Derived Peptide Release fromDays 17±17.5 (e17±e17.5) since it is at this age that the
Melanotrophspercentage of POMC-derived peptide-containing cells in the
IL becomes signi®cant (Pintar and Lugo, 1987; Lugo et al., 1. The dopamine agonist 2-bromo-a-ergocryptine (ERG;
1006 M) was used to investigate the inhibition of basal re-1989) and dissection of the pituitary into AL and NIL can
be performed reliably and consistently. The secretory re- lease of POMC-derived peptides from NIL cells of a variety
of ages (e17.5, e19.5, e21, p2, p3, and p5). In these experi-sponses of immunocytochemically identi®ed fetal (e17.5,
e19.5, and e21) and neonatal (Postnatal Days 2, 3, and 5; ments, ERG (1006 M) incubation began 45 min prior to addi-
tion of b-endorphin antiserum and continued throughoutp2, p3, and p5) melanotrophs to CRH and dopamine were
investigated. Furthermore, since evidence has suggested the duration of the experiment. ERG was used instead of
dopamine since it is more stable than the latter (Antaklythat adult melanotrophs can increase the level of GR if
deprived of neural input in vivo or in vitro and that this et al., 1987); in addition, 1 mM ascorbic acid was included
in all ERG-containing solutions in order to minimize oxida-increase can be inhibited by incubation with dopamine or
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tion (Loef¯er et al., 1988). Initial experiments determined
that 1006 M ERG was the lowest ERG concentration that
inhibited basal release in e21 NIL cultures, and this concen-
tration was used in all subsequent experiments. Comple-
ment addition and subsequent treatment of the chambers
was as described (Lugo and Pintar, 1996).
2. Glucocorticoid inhibition of CRH (1007 M) stimula-
tion was tested in isolated NIL from e19.5 to p5. In these
experiments, incubation with DEX (1006 M) began 45 min
prior to addition of CRH (1007 M) and b-endorphin antise-
rum; incubation with DEX continued throughout the dura-
tion of the experiment. Initial experiments performed with
isolated AL cells determined that 1006 M DEX produced the
greatest inhibition of the CRH stimulatory response (Lugo
and Pintar, 1996). Additional experiments have shown that
inhibitory effects of DEX on CRH-stimulated transcription
occur even at 1008 DEX (Scott and Pintar, 1993). Subsequent
treatment of chambers was as described (Lugo and Pintar,
1996).
3. ERG (1006 M) inhibition of CRH (1007 M) stimulation FIG. 1. Summary of the ontogeny of basal and regulated release
was tested at two ages (e19.5 and e21). These experiments from melanotrophs. At e17.5 mean plaque areas were unchanged
were carried out as above but ERG (1006 M) was substituted in the presence or absence of CRH, but decreased in the presence
for DEX (1006 M). of ERG to values below basal (P £ 0.05). Statistically signi®cant
(P £ 0.05) increases in plaque size following incubation with CRH
were observed beginning at e19.5 and continued throughout all
other older ages examined. Inhibition of CRH stimulation by theRESULTS
synthetic glucocorticoid DEX was only observed between the ages
e19.5 and p2. DEX inhibited CRH-stimulated b-endorphin secre-Melanotrophs from isolated NIL were capable of basal
tion to levels statistically (P £ 0.05) similar to control. Beginningsecretion beginning at the earliest stages examined (embry-
at p3, DEX no longer inhibited CRH stimulation of b-endorphinonic day 17.5, e17.5; Fig. 1). At this age, release of POMC-
release from intermediate lobe cells. Each bar represents the mean
related peptides could not be enhanced even in the presence { SEM of three experiments (25 plaque areas/experiment). *Sig-
of a high CRH concentration (1007 M); thus plaque sizes ni®cantly different from other treatments within age. **Signi®-
obtained upon incubation with CRH (1007 M) were not sig- cantly different than control.
ni®cantly different (P £ 0.05) than those obtained in the
absence of CRH (Fig. 1). A stimulatory response of melano-
trophs to CRH (1008 M) was ®rst observed at e19.5. At this
age, plaque areas obtained upon incubation with CRH (1007 produced an increase in plaque size (Fig. 1) paralleled with
an increase in the percentage of plaque-producing cells overM) (Figs. 1 and 2A) were signi®cantly (P £ 0.05) larger than
control values (Figs. 1 and 2B). The response to CRH was control values (Table 1). At all ages studied, there was a
subset of immunostained cells that did not form plaquesdose-dependent and larger plaques were obtained with
larger CRH concentrations at the ages tested, e19.5 (Fig. 3) even upon CRH stimulation.
Melanotroph secretion was inhibited by the dopamineand p3. The stimulatory effect of CRH on plaque size per-
sisted in all subsequent ages studied (e21 and p2, p3, and agonist ERG (1006 M) beginning at the earliest age examined
(e17.5), with plaque areas obtained after 45 min preincuba-p5 (Fig. 1). The melanotroph response to CRH incubation
was heterogeneous. Some cells responded to CRH robustly, tion with ERG signi®cantly (P £ 0.05) smaller than control
(basal) plaque areas (Fig. 1). This effect persisted throughoutproducing very large plaques, others responded moderately,
while still others did not show an increase in plaque size all ages examined (e19.5, e21, p2, p3, p5; Fig. 1).
The ability of ERG (1006 M) to inhibit CRH-stimulatedabove control values (see for example e21, Fig. 4). Plaque
sizes under basal conditions were smaller and more homo- POMC peptide release was studied in two age groups, e19.5
and e21. Preincubation with ERG (1006 M; 45 min) abol-geneous (Fig. 4). Incubation with CRH (1007 M) also had a
stimulatory effect on the percentage of melanotrophs that ished the increase in plaque size normally obtained after
incubation with CRH (1007 M) alone; thus the values ob-formed plaques (Table 1). This effect chronologically paral-
leled the CRH effect on increased plaque size. At e17.5, tained upon CRH (1007 M) addition following 45 min prein-
cubation with ERG (1006 M) were not signi®cantly (P £when incubation with CRH (1007 M) had no effect on plaque
size, the percentage of b-endorphin immunostained cells 0.05) different from control values (see for example, e21,
Fig. 5).that produced plaques in its presence or absence was virtu-
ally identical (48 and 47%, respectively, Table 1). At e19.5 Glucocorticoid effects on CRH-stimulated POMC pep-
tide release were examined beginning at e19.5, the age whenand in all older ages studied, incubation with CRH (1007 M)
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FIG. 2. Response of melanotrophs to secretory regulators at e21. Plaque areas are larger in the presence (A) versus the absence (B) of
CRH.
CRH (1007 M) enhancement of secretion was ®rst detected. Cells were immunostained with b-endorphin antiserum
following the plaque assay in order to determine the per-At this age, a 45-min preincubation with DEX (1006 M) abol-
ished the increase in plaque area observed upon incubation centage of melanotrophs in the total NIL cell population at
different ages as well as the possible effect of incubationwith CRH (1007 M) alone (Fig. 1). The plaque areas obtained
after addition of CRH (1007 M) following a 45-min preincu- with CRH (1007 M) upon the percentage of plaque-producing
melanotrophs. The percentage of melanotrophs in the totalbation with DEX (1006 M) were not signi®cantly (P £ 0.05)
different from those obtained upon basal conditions (Fig. 1). NIL cell population increased steadily throughout prenatal
life and remained virtually unchanged throughout all post-Moreover, the plaque size distribution with both treatments
was nearly identical (see for example e21 responses, Fig. 4). natal ages studied (Table 1). At e17.5 melanotrophs com-
prised 32% of the NIL cell population, at e21 their percent-This inhibitory effect of DEX (1006 M) persisted through
Postnatal Day 2 (Fig. 1). Beginning at p3, the inhibitory age had increased to 47 and by p2 they comprised 57% of
the NIL population (Table 1). As mentioned previously,effect of DEX on CRH (1007 M)-stimulated release from mel-
anotrophs was no longer present (Fig. 1). This lack of inhibi- while CRH incubation signi®cantly (P 0.05) increased the
percentage of melanotrophs that formed plaques beginningtion by DEX (1006 M) was also observed in the oldest postna-
tal age examined, p5 (Fig. 1). at e19.5 (Table 1), there was a subpopulation of melano-
trophs that did not form plaques even upon incubation with
a high (1007 M) CRH concentration.
DISCUSSION
While POMC mRNA-containing cells in the IL could be
detected as early as e15, signi®cant POMC-derived peptide
immunoreactivity was not detected prior to e17 (Pintar and
Lugo, 1987; Lugo et al., 1989). We, therefore, began our
studies of the ontogeny of basal and regulated secretion
from individual melanotrophs at e17±e17.5. In addition, at
this age we could separate the NIL from the AL reliably.
At e17.5 melanotrophs are capable of secreting POMC-
derived peptides but do not respond to CRH even at high
concentration (1007 M). This initial lack of responsiveness
to CRH by melanotrophs mimics the behavior of their
FIG. 3. CRH dose±response curves for melanotrophs. CRH dose± young (e13.5) AL counterparts (Lugo and Pintar, 1995). Lack
response curves were performed for melanotrophs at e19.5 and p3
of responsiveness to CRH may be due to absence of CRHfrom isolated NIL. Represented here are the mean values obtained
receptors, failure of coupling of CRH receptors to adenylateat e19.5. Statistically signi®cant (P£ 0.05) increases in plaque areas
cyclase, or lack of function of protein kinase A substratesabove basal levels are observed with CRH concentrations equal to
involved in CRH activation of secretion. Studies of the on-1008 M and higher. Each value represents the mean { SEM of 25
plaques. togeny of the recently cloned rat CRH receptor (Perrin et
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FIG. 4. Plaque area distributions of e21 melanotrophs following no treatment, CRH treatment, ERG treatment, or CRH±DEX treatment
(45-min preincubation with DEX). Melanotrophs respond heterogenously to CRH stimulation, while plaque sizes obtained upon CRH±
DEX treatment are not signi®cantly (P £ 0.05) different from basal values, have a similar size distribution, and are more homogeneous.
Plaque sizes obtained upon ERG treatment are signi®cantly (P £ 0.05) smaller than basal values.
al., 1993) in addition to direct activation of the cAMP path- and Mains (1986) in neonatal NIL cultures, the response of
prenatal NIL cells does not reach a plateau even at highway by 8-Br-cAMP or forskolin in e17 melanotrophs are
necessary in order to distinguish between these possibili- (1007 M) CRH concentrations. Although the reason for this
observation remains uncertain, it must be noted that theties.
CRH (1008 M) stimulation of secretion was ®rst observed population assayed here contains at all times cells at differ-
ent stages of differentiation which have not achieved adultat e19.5. This response was similar to that observed in the
adult IL (Meunier et al., 1982; Vale et al., 1983) and contin- steady-state values of POMC mRNA/cell (Lugo et al., 1989)
or POMC peptide content/cell (Sato and Mains, 1986).ued throughout all other older ages studied. As in the adult
(Meunier et al., 1982; Vale et al., 1983; Loef¯er et al., 1988), While the ontogeny of CRH receptors has not been studied
thus far, it is likely that their number and functional statusthe stimulatory effect of CRH could be abolished by prein-
cubation with the dopamine agonist ERG. Thus far, CRH also change as development proceeds. Changes in any or all
of these parameters may be responsible for the inability ofeffects on fetal or neonatal melanotroph secretion have only
been studied in superfused human NIL (fetus; Gibbs et al., differentiating melanotrophs to achieve plateau levels in
response to CRH. Furthermore, the present studies demon-1982) and in cultured rat pituitaries (neonate; Sato and
Mains, 1986). Gibbs et al. (1982) did not observe a stimula- strate that CRH stimulates hormone release from fetal/neo-
natal melanotrophs via two mechanisms: (1) increase in thetory effect of CRH on NIL from fetuses 19 to 23 weeks of
gestation. In the neonatal rat, Sato and Mains (1986) showed hormonal release from individual melanotrophs (larger
plaque areas); (2) increase in the percentage of melanotrophsapproximately a twofold stimulation over the IL basal secre-
tory rate upon CRH (1007 M) exposure which was lower that form plaques.
Hotta et al. (1988), in their superfusion studies of wholethan that observed in the AL. Our results not only con®rm
those of Sato and Mains (1986) but extend their observations embryonic rat pituitary glands, showed increases in a-MSH
secretion at e17 upon incubation with CRH (10011±10010to prenatal ages. We demonstrated that while the fetal AL
is responsive to CRH concentrations as low as 10010 M (Lugo M) and inferred that this secretion was of IL origin. The
present studies show that e17 melanotrophs do not respondand Pintar, 1996), plaque sizes from IL cells did not increase
signi®cantly above control values at CRH concentrations to CRH even at concentrations as high as 1007 M and a
response to CRH was not detected prior to e19.5. Further-lower than 1008 M. Consistent with the observations of Sato
Copyright q 1996 by Academic Press, Inc. All rights of reproduction in any form reserved.
/ m4592$8074 12-08-95 23:59:28 dbal Dev Bio
115Intermediate Lobe POMC Cell Secretion
TABLE 1 as b-adrenergic receptors (Cote et al., 1980; Schimcho-
Effect of CRH on Melanotroph Plaque Formation witsch and Pelletier, 1988) and to respond to CRH (Meunier
et al., 1982; Vale et al., 1983) and b-adrenergic receptor
Percentage of agonists (Przewlocki et al., 1979; Cote et al., 1980; Petti-
immunostained cells bone and Mueller, 1982) by increasing POMC-derived pep-Percentage ofwith plaques
tide secretion. Thus, a phenomenon similar to that observedimmunostained cells/
by Childs and Burke (1987) on AL corticotrophs in whichAge Control CRH total NIL cells
maximal stimulation of secretion by these cells required
e17.5 47 48 32 the action of multiple secretagogues, might also exist for
e19.5 44 56a 38 IL melanotrophs.
e21 40 55a 47 The ontogeny of the rat dopamine D2 receptor has been
p2 43 61a 57
investigated both, by ligand binding assays (Sales et al.,p5 48 65a 56
1989) as well as in-situ hybridization histochemistry (Rene
Note. The percentage of melanotrophs was calculated from the et al., 1994). In agreement with our data, both D2 receptor
number of immunolabeled cells following b-endorphin immunocy- mRNA as well as D2 receptors have been detected in the
tochemistry and the total number of cells on slides previously sub- IL as early as e17 which roughly coincides with the time
jected to reverse hemolytic plaque assays. The percentage of plaque- when we ®rst examined and detected a response to the dopa-
forming melanotrophs was also determined. n  1000 cells for mine agonist ERG. Thus far, only a few studies have investi-
percent plaque-forming cells/treatment; n  2000 for percent of gated the responses of neonatal rodent IL to dopamine and
melanotrophs from total number of cells.
shown that melanotrophs are responsive to dopamine froma Statistically different (0.05) compared to age-matched control
the time of birth (Schmitt et al., 1981; Davis et al., 1984;cells using paired t test.
Sato and Mains, 1986). Our studies extend these results to
the fetal period and demonstrate that these receptors are
appropriately coupled to inhibit secretion many days prior
to arrival of the dopaminergic input into the IL (p2, Davismore, fetal melanotrophs (unlike corticotrophs, Lugo and
Pintar, 1996; see above) exhibited no response to CRH at et al., 1984). Thus, the development of functional dopamine
receptors on melanotrophs appears to be independent ofconcentrations lower than 1008 M. Moreover, biochemical
studies of peptide forms during fetal life have demonstrated hypothalamic dopaminergic in¯uence, although in¯uence
from other areas such as neural lobe or basal lamina compo-that a-MSH is not detected in the fetal IL until e19 (Allen
et al., 1984). In addition, the presence of a-MSH-like pep- nents can not be ruled out. For example, in-vitro studies of
the rabbit pituitary showed that normal IL morphology intides has been demonstrated in the fetal and neonatal AL
by immunocytochemistry (Kachaturian et al., 1983; Sato this species is dependent on contact between adenohypo-
and Mains, 1985) and demonstrated to be des-acetyl-a-MSH
by peptide analysis (Pintar et al., 1986; Pintar and Lugo,
1987). Taken together, the aforementioned results indicate
that Hotta et al.'s (1988) observations likely re¯ect des-
acetyl-a-MSH secretion originating from corticotrophs
rather than melanotrophs.
At all ages studied, there was a subpopulation of b-endor-
phin immunostained melanotrophs that did not form
plaques even upon CRH (1007 M) incubation. Since no study
at the single cell level exists in the adult IL, it is not known
whether every melanotroph releases POMC-derived pep-
tides under basal or stimulated conditions. It is nonetheless
known, that normally, the rat IL contains what has been
described as dark and light melanotrophs. This difference
in tinctorial properties has been interpreted to re¯ect differ-
ences in cell activity (Chronwall et al., 1987, 1988). For
example, a single injection of haloperidol (a dopamine an-
tagonist) to intact animals increases the proportion of dark
(active) melanotrophs and the number of silver grains over
the cells after in-situ hybridization autoradiography with
POMC-speci®c probes. Similar treatment with ergocryptine
FIG. 5. ERG inhibition of basal and CRH-stimulated b-endorphin
(a dopamine agonist) has opposite effects (Chronwall et al., secretion from e21 melanotrophs. A 45-min preincubation with
1987). Perhaps the differences in tinctorial properties of ERG produced inhibition of basal as well as CRH-stimulated re-
these cells may also re¯ect differences in the secretory state lease as determined by signi®cant (P £ 0.05) decreases in mean
of individual melanotrophs. In addition, melanotrophs have plaque areas. Each bar represents the mean { SEM of 25 values.
*Statistically different from all other treatments.been shown to possess CRH (De Souza et al., 1984) as well
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physial cells and the neural lobe (Gaillard, 1937). In addi- GR gene expression during rat pituitary ontogeny utilizing
in-situ hybridization histochemistry techniques (Cintra ettion, in species such as whales where the neural lobe never
comes in direct contact with Rathke's pouch, the IL is ab- al., 1993; Rene et al., 1994) have been inconclusive. For
example, Cintra et al. (1993) reported no information aboutsent (Wislocki and Geiling, 1936).
Dopamine inhibition of POMC-derived peptide secretion hybridization signal over the IL, while Rene et al. (1994)
failed to detect signal over the presumptive IL after e15.was present at e17.5 when responsiveness to CRH was un-
detectable even at high (1007) CRH concentration. Since Failure to detect signal over the IL by conventional in-situ
hybridization techniques may re¯ect very low levels of GRboth CRH and dopamine have been shown to exert their
in¯uence on melanotrophs via a cAMP-dependent mecha- mRNA that may require more sensitive methods such as
PCR in-situ hybridization for optimal detection. Neverthe-nism (Meunier et al., 1982; Cote et al., 1986), the simplest
explanation for the temporal discrepancy observed in these less, in our experiments, the loss of response to glucocorti-
coids coincides with the arrival of dopaminergic input intoresponses would be an absence of functional CRH receptors
prior to e19.5. Thus far, no study has directly assessed the the IL (Davis et al., 1984). This is particularly interesting
because although the adult IL has been shown to have im-ontogeny of CRH receptors in the rat pituitary (see above).
On the other hand, Loef¯er et al. (1988) have shown that the munodetectable levels of GR (Bertini et al., 1989), these
cells are not responsive to glucocorticoids under normaldopamine effect also has a cAMP-independent component.
Direct stimulation of the cAMP pathway by 8-Br-cAMP or conditions (Eberwine and Roberts, 1984). However, when
hypothalamic input is removed by denervation (Seger et al.,forskolin does not completely abolish the D2 receptor-me-
diated inhibition of POMC peptide secretion or POMC 1988) or incubation of NIL cells in vitro for various days
(Eberwine et al., 1987), IL cells become responsive to gluco-mRNA synthesis in serum-free adult rat melanotroph cul-
tures. Moreover, pretreatment with pertussis toxin almost corticoids. Moreover, IL cells that have been maintained in
culture for 6 days show high levels of GR which decreasecompletely abolishes the bromocryptine effect on POMC
transcription and secretion, suggesting that the dopaminer- substantially 48 hr after incubation with dopamine or its
agonist bromocryptine (Antakly et al., 1987). In contrast,gic inhibition is mediated at least in part by guanosine tri-
phosphate binding proteins (GTP-BP). These proteins have dopamine agonists have no effect on GR levels in AL cells
under identical conditions (Antakly et al., 1987). Togetherbeen shown to have a role as signal transducers in the nor-
adrenaline and g-aminobutyric acid-induced inhibition of these data suggest that dopaminergic input to the IL may
somehow affect the ability of melanotrophs to respond tovoltage-dependent calcium channels in primary cultures of
embryonic chick dorsal root ganglia neurons (Holz et al., glucocorticoids regardless the presence of GR in these cells.
Although the exact mechanism underlying this phenome-1986). These data, together with the demonstration that
dopamine blocks voltage-dependent calcium channels in non is at present unknown, studies by Sheppard et al. (1993)
show that pretreatment of DEX-insensitive IL-derived cellssome cells of the rat IL (Douglas and Taraskevich, 1982),
suggest that the cAMP-independent component of the dopa- in culture with the protein synthesis inhibitor puromycin
prior to DEX addition, leads to DEX inhibition of CRH-mine inhibition can be effected via GTP-BP-mediated inhi-
bition of voltage-sensitive calcium channels. If the cAMP- stimulated transcription. This result suggests that a rapidly
metabolized protein(s) may be mediating the inhibition ofdependent and independent mechanisms mature at differ-
ent times during melanotroph differentiation, this would function of the GR in adult melanotrophs, and, in this re-
gard, it is interesting that negative regulation of the mouseexplain the difference observed here between the age when
dopamine agonists ®rst inhibit POMC-derived peptide re- proliferin gene by glucocorticoids depends not only on GR
but also on fos/jun components of the AP1 transcriptionlease (e17.5) and the time when CRH ®rst stimulates POMC
release (e19.5). complex (Diamond et al., 1990).
In summary, the fetal IL is capable of basal release as wellOur studies clearly demonstrate that functional glucocor-
ticoid responses can be transiently elicited during melano- as adult-like responses to CRH and dopamine agonist prior
to birth. The latter responses can be elicited many daystroph ontogeny. Glucocorticoid inhibition of CRH stimula-
tion was present between e19.5 and p2. After p2, preincuba- prior to arrival of dopaminergic input into the IL. Thus,
development of functional dopamine receptors appears to betion with glucocorticoids had no effect on CRH stimulation
of release. Studies by Scott and Pintar (1993) have shown independent of hypothalamic input. Finally, melanotrophs
respond transiently to glucocorticoids demonstrating thethat 30 min preincubation with DEX or the type II GR
agonist RU 28362 (as low as 1008 M) prior to CRH addition presence of functional GR in melanotrophs during IL ontog-
eny. This response is lost after the time of arrival of dopa-can inhibit CRH-stimulated increases in POMC hnRNA in
short-term cultures of NIL from p1 but not p10 neonatal minergic input into the IL. Thus, it appears that dopamine
inhibition of GR expression/function is a normal event inrats. Thus, both secretory and transcriptional effects are
affected over the same time course and, taken together, melanotroph differentiation.
demonstrate that a transient glucocorticoid response char-
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